{"id":"https://openalex.org/W1997156360","doi":"https://doi.org/10.1089/108076802321021108","title":"In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System","display_name":"In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System","alternate_titles":[],"publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W1997156360","doi":"https://doi.org/10.1089/108076802321021108","mag":"1997156360","pmid":"https://pubmed.ncbi.nlm.nih.gov/12537682"},"language":"en","primary_location":{"id":"doi:10.1089/108076802321021108","doi":"https://doi.org/10.1089/108076802321021108","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108076802321021108","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997156360"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079079941","display_name":"Lars P. J. Cruysberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I4210094864","display_name":"Emory Eye Center","ror":"https://ror.org/00hr6kp69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4210094864","https://openalex.org/I4210109911"]}],"countries":["NL","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars P. J. Cruysberg","raw_affiliation_strings":["Department of Ophthalmology, Emory, Atlanta, Georgia and Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Emory, Atlanta, Georgia and Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht, The Netherlands","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I2800191616","https://openalex.org/I4210094864"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073185907","display_name":"Rudy M.M.A. Nuijts","orcid":"https://orcid.org/0000-0003-2218-9660","observed_orcids":["https://orcid.org/0000-0003-2218-9660"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rudy M. M. A. Nuijts","raw_affiliation_strings":["Department of Ophthalmology and Center of Biomaterials, University Hospital of          Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Center of Biomaterials, University Hospital of          Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038576932","display_name":"Dayle H. Geroski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dayle H. Geroski","raw_affiliation_strings":["Department of Ophthalmology, Emory, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Emory, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109528945","display_name":"L\u00e9o H. Koole","orcid":"https://orcid.org/0000-0002-6430-4893","observed_orcids":["https://orcid.org/0000-0002-6430-4893"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leo H. Koole","raw_affiliation_strings":["Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht,          The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht,          The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111959219","display_name":"Fred Hendrikse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fred Hendrikse","raw_affiliation_strings":["Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083984022","display_name":"Henry F. Edelhauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry F. Edelhauser","raw_affiliation_strings":["Department of Ophthalmology, Emory, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Emory, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1965,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.83196415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"18","issue":"6","first_page":"559","last_page":"569"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scleral-permeability","display_name":"scleral permeability","score":0.9869999885559082},{"id":"https://openalex.org/keywords/fluorescein","display_name":"fluorescein","score":0.8080000281333923},{"id":"https://openalex.org/keywords/rhodamine-6g","display_name":"rhodamine 6G","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8029999732971191},{"id":"https://openalex.org/keywords/molecular-weight","display_name":"molecular weight","score":0.5320000052452087},{"id":"https://openalex.org/keywords/lipid-solubility","display_name":"lipid solubility","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.5419999957084656},{"id":"https://openalex.org/keywords/fluorescein-clearance","display_name":"fluorescein clearance","score":0.4300000071525574},{"id":"https://openalex.org/keywords/choroidal-circulation","display_name":"choroidal blood flow","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2778015030","wikidata":"https://www.wikidata.org/wiki/Q410922","display_name":"Fluorescein","level":3,"score":0.9354090690612793},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5164070725440979},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.511307954788208},{"id":"https://openalex.org/C2779916640","wikidata":"https://www.wikidata.org/wiki/Q420410","display_name":"Rhodamine","level":3,"score":0.49017244577407837},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.46532508730888367},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.36849159002304077},{"id":"https://openalex.org/C91881484","wikidata":"https://www.wikidata.org/wiki/Q191807","display_name":"Fluorescence","level":2,"score":0.26565733551979065},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1952352523803711},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13899493217468262},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0786815881729126},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07495003938674927},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012235","descriptor_name":"Rhodamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012590","descriptor_name":"Sclera","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000295","qualifier_name":"instrumentation","is_major_topic":true},{"descriptor_ui":"D019793","descriptor_name":"Fluorescein","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020099","descriptor_name":"Coated Materials, Biocompatible","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/108076802321021108","doi":"https://doi.org/10.1089/108076802321021108","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108076802321021108","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:12537682","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12537682","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000860143","display_name":"P30-Core Grant for Vision Research","funder_award_id":"P30EY006360","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"}],"funders":[{"id":"https://openalex.org/F4320306811","display_name":"Research to Prevent Blindness","ror":"https://ror.org/04drjs621"},{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W17499265","https://openalex.org/W46341933","https://openalex.org/W59239023","https://openalex.org/W1225376777","https://openalex.org/W1568901762","https://openalex.org/W1749875967","https://openalex.org/W1976620157","https://openalex.org/W1978576791","https://openalex.org/W1986180285","https://openalex.org/W1996853317","https://openalex.org/W2002383658","https://openalex.org/W2005113554","https://openalex.org/W2006566960","https://openalex.org/W2021592080","https://openalex.org/W2025828477","https://openalex.org/W2059541476","https://openalex.org/W2069557849","https://openalex.org/W2085091748","https://openalex.org/W2086373689"],"related_works":["https://openalex.org/W2125071803","https://openalex.org/W2164136888","https://openalex.org/W2067055244","https://openalex.org/W2089486173","https://openalex.org/W2405981774","https://openalex.org/W2170567083","https://openalex.org/W2024957445","https://openalex.org/W2119158870","https://openalex.org/W2006692948","https://openalex.org/W2051900738"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"determine":[2],"the":[3,85,92,109,120,162,165,173,176,200,211],"in":[4,53,77,229],"vitro":[5],"human":[6,49],"scleral":[7,36,208,230],"permeability":[8,37,174,209,231],"of":[9,61,65,80,175,207,242],"several":[10],"dyes":[11,122,213],"and":[12,20,26,38,99,123,155,180,189,236,247],"drugdye":[13],"combinations":[14,125],"with":[15,30],"varying":[16],"molecular":[17],"weights":[18],"(MW)":[19],"lipid":[21,237],"solubilities":[22],"(fluorescein,":[23],"dexamethasone-fluorescein,":[24,69,140],"methotrexate-fluorescein,":[25,147],"rhodamine).":[27],"Coils":[28],"coated":[29,75],"rhodamine":[31,154,163,190,201,221,224,243],"were":[32,51,126],"also":[33],"evaluated":[34],"for":[35,101,119,132,139,146,153,161],"sustained":[39],"release.":[40],"METHODS:":[41],"Scleral":[42],"sections":[43],"excised":[44],"from":[45,108,164,199],"moist":[46],"chamber":[47],"stored":[48],"globes":[50],"mounted":[52],"a":[54,74,169],"2-compartment":[55],"perfusion":[56],"chamber.":[57],"A":[58],"small":[59],"depot":[60],"drug/dye":[62],"(100":[63],"microl":[64,79],"10(-4)":[66],"M":[67],"fluorescein,":[68,133],"methotrexate-fluorescein":[70,185,219],"or":[71,73],"rhodamine)":[72],"coil":[76,222,249],"100":[78],"BSS":[81,90],"was":[82,97,104,197],"added":[83],"to":[84,91,178,210,234],"episcleral":[86],"surface":[87],"while":[88],"perfusing":[89],"choroidal":[93],"side.":[94],"The":[95,204],"perfusate":[96],"collected":[98],"measured":[100],"fluorescence.":[102],"Permeability":[103],"calculated":[105],"as":[106,215],"Ktrans":[107,113],"flux":[110,196],"measurements.":[111],"RESULTS:":[112],"values":[114],"(cm/sec,":[115],"mean":[116],"+/-":[117,128,135,142,149,157],"SE)":[118],"studied":[121,212],"drug-dye":[124],"5.21":[127],"0.71":[129],"x":[130,137,144,151,159],"10(-6)":[131,138,145,152,160],"1.64":[134],"0.17":[136],"3.36":[141],"0.62":[143],"1.86":[148],"0.39":[150],"2.18":[156],"0.23":[158],"coils.":[166],"We":[167],"found":[168],"significant":[170],"difference":[171],"between":[172],"sclera":[177],"fluorescein":[179,217],"dexamethasone-fluorescein":[181],"(P":[182,186,191],"<":[183,187,192],"0.001),":[184],"0.05)":[188],"0.001).":[193],"Steady":[194],"state":[195],"observed":[198],"coil.":[202],"CONCLUSION:":[203],"rank":[205],"order":[206],"is":[214],"follows:":[216],">":[218,220,223,226],"6G":[225],"dexamethasone-fluorescein.":[227],"Differences":[228],"are":[232,250],"related":[233],"MW":[235],"solubility.":[238],"Prolonged":[239],"transscleral":[240],"diffusion":[241],"delivered":[244],"by":[245,248],"solution":[246],"similar.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997156360","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
